Pricing Log in Create free account

Biomea Fusion, Inc. (BMEA) vs iBio, Inc. (IBIO)

Biomea Fusion, Inc. and iBio, Inc. are both Biotechnology companies. Biomea Fusion, Inc. and iBio, Inc. are of similar size ($44.4M and $42.6M). Across the 9 metrics below, iBio, Inc. leads on 8 and Biomea Fusion, Inc. on 1.

Valuation

Metric BMEA IBIO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 115.62 9.40
P/B 3.34 0.91 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.25 0.66
EV/Sales n/m (12.78) 9.02
Earnings yield (88.54%) (45.33%) (32.88%)
Free cash flow yield (115.76%) (31.04%) (23.13%)

Profitability

Metric BMEA IBIO Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (164.14%) (65.70%) (51.96%)
Return on assets (59.14%) (54.04%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BMEA IBIO Biotechnology median
Revenue growth (TTM) — (66.55%) 6.76%
EPS growth (last fiscal year) 69.19% 81.71% 29.88%
Revenue growth, 5-year CAGR — (42.83%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BMEA IBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.48 7.85 4.97
Net debt to EBITDA 0.68 2.57 1.01

Dividend

Metric BMEA IBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BMEA IBIO Biotechnology median
Market cap 42.57m 44.43m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack